Clinical decision rules accurately predict stroke risk in atrial fibrillation
The Journal of Family Practice. 2005 April;54(4):303-309
April 1, 2005|The Journal of Family Practice
Author and Disclosure Information
- Clinical Question: Which patients with atrial fibrillation would benefit from anticoagulation?
- Study Design: Decision rule (validation)
- Setting: Various (meta-analysis)
- Synopsis: A knee-jerk response of atrial fibrillation = anticoagulation no longer works. If the risk of stroke is low (<2%), the harms of anticoagulation generally outweigh the benefits. If the risk of stroke is high (>4%), the benefits of anticoagulation outweigh the risks for most patients. If the patient’s stroke risk is in between both extremes, we have to look carefully at his or her risk for hemorrhage.
Bottom Line
Clinical decision rules, especially the well-validated Stroke Prevention in Atrial Fibrillation (SPAF) score, can help identify which groups of patients with atrial fibrillation are likely and unlikely to benefit from anticoagulation. (LOE=1a)
